ChiCTR2200059702 版本V1.0 版本创建时间2023/02/23 16:36:42 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2200059702 

最近更新日期:

Date of Last Refreshed on:

2022-05-08 21:48:57 

注册时间:

Date of Registration:

2022-05-08 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

基于草果和沉香的芳香疗法对脑卒中后抑郁的影响的功能性近红外光谱研究

Public title:

Functional near-infrared spectroscopy of the effects of aromatherapy based on Amommum tsaoko Crevost et Lemaire and Aquilaria sinensis Lour on post-stroke depression

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于草果和沉香的芳香疗法对脑卒中后抑郁的影响的功能性近红外光谱研究

Scientific title:

Functional near-infrared spectroscopy of the effects of aromatherapy based on Amommum tsaoko Crevost et Lemaire and Aquilaria sinensis Lour on post-stroke depression

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

李夏 

研究负责人:

李夏 

Applicant:

Xia Li 

Study leader:

Xia Li 

申请注册联系人电话:

Applicant telephone:

15258638622

研究负责人电话:

Study leader's
telephone:

15258638622

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

xiaxiali_1@163.com

研究负责人电子邮件:

Study leader's E-mail:

xiaxiali_1@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

温州市中医院

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

中国浙江省温州市鹿城区蛟尾路9号温州市中医院

研究负责人通讯地址:

中国浙江省温州市鹿城区蛟尾路9号温州市中医院

Applicant address:

Zhejiang Chinese Medical University Affiliated Wenzhou Hospital of Traditional Chinese Medicine, No.9 Jiaowei Road, Lucheng District, Wenzhou, Zhejiang, China.

Study leader's address:

Zhejiang Chinese Medical University Affiliated Wenzhou Hospital of Traditional Chinese Medicine, No.9 Jiaowei Road, Lucheng District, Wenzhou, Zhejiang, China.

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

温州市中医院

Applicant's institution:

Zhejiang Chinese Medical University Affiliated Wenzhou Hospital of Traditional Chinese Medicine

研究负责人所在单位:

Affiliation of the Leader:

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

WZY2022-LW-001-01

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

温州市中医院伦理委员会

Name of the ethic committee:

Ethics Committee of the Zhejiang Chinese Medical University Affiliated Wenzhou Hospital of Traditional Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

1990-01-01 00:00:00

伦理委员会联系人:

朱雪梅

Contact Name of the ethic committee:

Xuemei Zhu

伦理委员会联系地址:

中国浙江省温州市鹿城区蛟尾路9号温州市中医院

Contact Address of the ethic committee:

Zhejiang Chinese Medical University Affiliated Wenzhou Hospital of Traditional Chinese Medicine, No.9 Jiaowei Road, Lucheng District, Wenzhou, Zhejiang, China.

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

温州市中医院

Primary sponsor:

Zhejiang Chinese Medical University Affiliated Wenzhou Hospital of Traditional Chinese Medicine

研究实施负责(组长)单位地址:

中国浙江省温州市鹿城区蛟尾路9号温州市中医院

Primary sponsor's address:

Zhejiang Chinese Medical University Affiliated Wenzhou Hospital of Traditional Chinese Medicine, No.9 Jiaowei Road, Lucheng District, Wenzhou, Zhejiang, China.

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

浙江

市(区县):

温州

Country:

China

Province:

Zhejiang

City:

Wenzhou

单位(医院):

温州市中医院

具体地址:

鹿城区蛟尾路9号

Institution
hospital:

Zhejiang Chinese Medical University Affiliated Wenzhou Hospital of Traditional Chinese Medicine

Address:

9 Jiaowei Road, Lucheng District

经费或物资来源:

自筹

Source(s) of funding:

Self-funded

研究疾病:

卒中后抑郁  

Target disease:

post-stroke depression

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

探讨基于草果和沉香的芳香疗法对脑卒中后抑郁的影响  

Objectives of Study:

Exploring the effects of aromatherapy based on Amommum tsaoko Crevost et Lemaire and Aquilaria sinensis Lour on post-stroke depression

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

(1)经CT或MRI诊断为脑卒中;(2)卒中发生后3个月内发生抑郁;(3)HAMD-24评分为8-30分;(4)年龄在60-80岁之间;(5)意识清晰,MMSE评分≥27;(6)生命体征稳定

Inclusion criteria

(1) ischemic stroke diagnosed by CT or MRI; (2) depression within 3 months after the occurrence of stroke; (3) HAMD-24 score between 8 and 34; (4) age between 60 and 80 years; (5) with clear consciousness, MMSE score ≥27; (6) stable vital signs.

排除标准:

(1)有严重的语言、听觉、视觉障碍;(2)其他精神障碍;(3)其他严重疾病;(4)NIHSS评分>10分

Exclusion criteria:

(1) serious language, hearing and visual impairments; (2) other mental disorders; (3) other severe diseases;(4) NIHSS>10

研究实施时间:

Study execute time:

From 2022-04-25 00:00:00 To 2023-06-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2022-04-25 00:00:00 To 2023-06-30 00:00:00

干预措施:

Interventions:

组别:

实验组

样本量:

20

Group:

Experiment group

Sample size:

干预措施:

每周进行2次心理咨询,每次30分钟,并嘱咐每天点燃一根草果和沉香制成的线香

干预措施代码:

Intervention:

2 psychological counseling per week for 30 minutes each time. And they were instructed to light a stick of incense made of Amomum tsaoko Crevost et Lemaire and Aquilaria sinensis Lour every day

Intervention code:

组别:

对照组

样本量:

20

Group:

Control group

Sample size:

干预措施:

每周进行2次心理咨询,每次30分钟

干预措施代码:

Intervention:

2 psychological counseling per week for 30 minutes each time

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

浙江 

市(区县):

 

Country:

China

Province:

Zhejiang

City:

单位(医院):

温州市中医院 

单位级别:

三甲 

Institution
hospital:

Zhejiang Chinese Medical University Affiliated Wenzhou Hospital of Traditional Chinese Medicine

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

功能性近红外光谱

指标类型:

主要指标

Outcome:

Functional near-infrared spectroscopy, fNIRS

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 60 years
最大 Max age 80 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

由医生根据随机数字表生成随机序列

Randomization Procedure (please state who generates the random number sequence and by what method):

Random sequence generated by a physician using the random number table method

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

N/A

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

N/A

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

N/A

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

N/A

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2022-05-08 21:48:58